The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Self-citationFinal Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Self-citationFinal Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,636
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L. V., Hassel, J. C., Rutkowski, P., Mohr, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203421 · Cited by 2,160
Self-citationKirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,094
Sentinel-Node Biopsy or Nodal Observation in Melanoma
Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Elashoff, R., Essner, R., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060992 · Cited by 1,824
Diagnostic accuracy of dermoscopy
Kittler, H., Pehamberger, H., Wolff, K., & Binder, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00679-4 · Cited by 1,349
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M. M., Демидов, Л. В., Hassel, J. C., Rutkowski, P. L., Mohr, P., et al. (2012) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-63198 · Cited by 1,330
Self-citationIpilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Margolin, K., Ernstoff, M. S., Hamid, O., Lawrence, D., McDermott, D., Puzanov, I., Wolchok, J. D., Clark, J. I., Sznol, M., Logan, T. F., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70090-6 · Cited by 1,091
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Su, F., Viros, A., Milagre, C., Trunzer, K., Bollag, G., Spleiss, O., Reis-Filho, J. S., Kong, X., Koya, R. C., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105358 · Cited by 1,038
Long, G. V., Trefzer, U., Davies, M. A., Kefford, R. F., Ascierto, P. A., Chapman, P. B., Puzanov, I., Hauschild, A., Robert, C., Algazi, A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70431-x · Cited by 918
Self-citationKirkwood, J. M., Ibrahim, J. G., Sondak, V. K., Richards, J., Flaherty, L. E., Ernstoff, M. S., Smith, T. J., Rao, U., Steele, M., & Blum, R. H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2444 · Cited by 912
Reduced melanoma after regular sunscreen use: randomized trial follow-up
Green, A. C., Williams, G. M., Logan, V., & Strutton, G. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7078 · Cited by 799
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F., & Detmar, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041896 · Cited by 719
Guo, J., Si, L., Kong, Y., Flaherty, K. T., Xu, X., Zhu, Y., Corless, C. L., Li, L., Li, H., Sheng, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.9275 · Cited by 688
Eggermont, A. M., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Salès, F., Gore, M., MacKie, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61033-8 · Cited by 640
Self-citationAscierto, P. A., Schadendorf, D., Berking, C., Agarwala, S. S., van Herpen, C. M., Queirolo, P., Blank, C. U., Hauschild, A., Beck, J. T., St-Pierre, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70024-x · Cited by 640
Self-citationDykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Mocellin, S., Pasquali, S., Rossi, C. R., & Nitti, D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq009 · Cited by 527
Oberholzer, P. A., Kee, D., Dziunycz, P., Sucker, A., Kamsukom, N., Jones, R., Roden, C., Chalk, C. J., Ardlie, K., Palescandolo, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.7680 · Cited by 386
Grob, J. J., & Bonerandi, J. J. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.1.103-a · Cited by 331
Burmeister, B. H., Henderson, M. A., Ainslie, J., Fisher, R., Di Iulio, J., Smithers, B. M., Hong, A., Shannon, K., Scolyer, R. A., Carruthers, S., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70138-9 · Cited by 293
Thompson, J. F., Scolyer, R. A., & Kefford, R. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17951-3 · Cited by 292
Eggermont, A. M. M., Suciu, S., Testori, A., Santinami, M., Kruit, W. H. J., Marsden, J., Punt, C. J. A., Salès, F., Dummer, R., Robert, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.3799 · Cited by 285
Self-citationWhiteman, D. C., Pavan, W. J., & Bastian, B. C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00880.x · Cited by 273
Zimmer, L., Hillen, U., Livingstone, E., Lacouture, M. E., Busam, K., Carvajal, R. D., Egberts, F., Hauschild, A., Kashani-Sabet, M., Goldinger, S. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.1660 · Cited by 231
Self-citationSalerni, G., Carrera, C., Lovatto, L., Puig-Butille, J. A., Badenas, C., Plana, E., Puig, S., & Malvehy, J. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.008 · Cited by 228
van der Ploeg, A. P. T., van Akkooi, A. C. J., Rutkowski, P., Nowecki, Z. I., Michej, W., Mitra, A., Newton-Bishop, J. A., Cook, M., van der Ploeg, I. M. C., Nieweg, O. E., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6760 · Cited by 208
Kim, K. B., Sosman, J. A., Fruehauf, J. P., Linette, G. P., Markovic, S. N., McDermott, D. F., Weber, J. S., Nguyen, H., Cheverton, P., Chen, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.6270 · Cited by 196
Eggermont, A. M. M., Suciu, S., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Santinami, M., Salès, F., Schadendorf, D., Patel, P., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.028 · Cited by 192
Self-citationRobert, C., Dummer, R., Gutzmer, R., Lorigan, P., Kim, K. B., Nyakas, M., Arance, A., Liszkay, G., Schadendorf, D., Cantarini, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70237-7 · Cited by 169
Self-citationSosman, J. A., Moon, J., Tuthill, R. J., Warneke, J. A., Vetto, J. T., Redman, B. G., Liu, P. Y., Unger, J. M., Flaherty, L. E., & Sondak, V. K. (2011) · Cancer · doi:10.1002/cncr.26111 · Cited by 168
van der Ploeg, A. P. T., van Akkooi, A. C. J., Haydu, L. E., Scolyer, R. A., Murali, R., Verhoef, C. K., Thompson, J. F., & Eggermont, A. M. M. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.023 · Cited by 147
Hollestein, L. M., van den Akker, S. A. W., Nijsten, T. E. C., Karim‐Kos, H. E., Coebergh, J. W. W., & de Vries, E. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr128 · Cited by 135
Prognostic false-positivity of the sentinel node in melanoma
Thomas, J. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1014 · Cited by 133
Melanoma incidence and mortality in Scotland 1979–2003
for and on behalf of the Scottish Melanoma Group, Mackie, R. M., Bray, C. A., Vestey, J. P., Doherty, V. R., Evans, A. T., Thomson, D., & Nicolson, M. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603801 · Cited by 118
Am, E., Suciu, S., Santinami, M., Testori, A., Kruit, W. H. J., Marsden, J. R., Punt, C. J. A., Salès, F., Gore, M. E., MacKie, R., et al. (2008) · Research Explorer (The University of Manchester) · Cited by 111
Self-citationBastiaannet, E., Wobbes, T., Hoekstra, O. S., van der Jagt, E. J., Brouwers, A. H., Koelemij, R., de Klerk, J. M. H., Oyen, W. J. G., Meijer, S., & Hoekstra, H. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1822 · Cited by 94
von Moos, R., Seifert, B., Simcock, M., Goldinger, S. M., Gillessen, S., Ochsenbein, A. F., Michielin, O. A., Cathomas, R. L., Schläppi, M., Moch, H., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr126 · Cited by 93
Self-citationSchoenewolf, N. L., Büll, C., Belloni, B., Holzmann, D., Tonolla, S., Lang, R., Mihic‐Probst, D., Andres, C., & Dummer, R. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.049 · Cited by 88
Self-citationSingle-agent interleukin-2 in the treatment of metastatic melanoma: A systematic review
Petrella, T. M., Quirt, I. C., Verma, S., Haynes, A. E., Charette, M. L., & Bak, K. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.04.003 · Cited by 87
Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma
Dummer, R., Guggenheim, M., Arnold, A., Braun, R. P., & von Moos, R. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13320 · Cited by 87
Self-citationBono, A., Tolomio, E., Trincone, S., Bartoli, C., Tomatis, S., Carbone, A., & Santinami, M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07396.x · Cited by 78 · cited 1×
“Today, many primary melanomas have a diameter of <5 mm [5].”
BackgroundBiochemotherapy for the treatment of metastatic malignant melanoma: A systematic review
Hamm, C. M., Verma, S., Petrella, T. M., Bak, K., & Charette, M. L. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.10.003 · Cited by 75
Treatment of metastatic melanoma with electrochemotherapy
Campana, L. G., Testori, A., Mozzillo, N., & Rossi, C. R. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23512 · Cited by 56
Ascierto, P. A., Berking, C., Agarwala, S. S., Schadendorf, D., van Herpen, C., Queirolo, P., Blank, C. U., Hauschild, A., Beck, J. T., Zubel, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.8511 · Cited by 50
Self-citation
Cited by
Dummer, R., Ascierto, P. A., Gogas, H. J., Arance, A., Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsova, I., Gutzmer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30142-6 · Cited by 1,037
Self-citationTargeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Bahar, M. E., Kim, H. J., & Kim, D. R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01705-z · Cited by 888
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Guidelines of care for the management of primary cutaneous melanoma
Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., Guild, V., Grant-Kels, J. M., Halpern, A. C., Johnson, T. M., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.08.055 · Cited by 727
Domingues, B., Lopes, J., Soares, P., & Populo, H. (2018) · ImmunoTargets and Therapy · doi:10.2147/itt.s134842 · Cited by 701
Metadata
- Authors
- Dummer, R., Hauschild, A., Guggenheim, M., Keilholz, U., & Pentheroudakis, G.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 23
- Issue
- 12
- Pages
- vii86-vii91
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2116997650
- Cited by
- 714
- References
- 49
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.